Brazil Enteral Nutrition Market to Surpass US$ 460.8 Million by 2027, at a CAGR of 4.5% - Coherent Market Insights

News provided by

Mar 23, 2020, 11:53 ET

SEATTLE, March 23, 2020 /PRNewswire/ -- According to Coherent Market Insights, the Brazil enteral nutrition market is expected to be valued at US$ 323.7 million in 2019, and is projected to exhibit a CAGR of 4.5% over the forecast period (2019–2027).

Key Trends and Analysis of the Brazil Enteral Nutrition Market:

Key trends in the market are rising prevalence of chronic diseases such as diabetes, cardiovascular disease, cancer, and others, product launches, and collaboration and acquisition activities among key market players. According to the World Health Organization (WHO), in 2018, out of 1.3 million deaths in Brazil, around 74% were due to non-communicable diseases (NCDs), which include cardiovascular disease, diabetes, cancer, and chronic lung diseases.

Request for Sample PDF @ https://www.coherentmarketinsights.com/insight/request-sample/3540

An increasing number of product launches is expected to contribute to the growth of the Brazil enteral nutrition market over the forecast period. For instance, in March 2017, B. Braun Medical Ltd. launched a new range of nutritionally complete dietary drinks which include Nutricomp Drink Plus. It is an enteral nutrition product available in four flavors. The high-energy supplement can be prescribed for the dietary management of malnutrition.

Furthermore, key players operating in the market are focused on adopting acquisition and collaboration strategies, in order to expand their product offerings in markets. In January 2020, Nestlé acquired Zenpep from Allergen Pharmaceuticals. Zenpep is in the class of Pancreatic Enzyme Replacement Therapies (PERTs). It is used for treatment of patients with Exocrine Pancreatic Insufficiency (EPI) who cannot digest food properly because their pancreas does not provide enough enzymes to break down fat, protein, and carbohydrates. As a result of this strategic acquisition, Nestlé has expanded its medical nutrition business.

Key Market Takeaways:

The Brazil enteral nutrition market is expected to exhibit a CAGR of 4.5% over the forecast period, owing to rising prevalence of chronic diseases, increasing awareness about enteral nutrition products and product launches. For instance, in July 2018, Nestlé launched a vegan baby formula for infants with milk allergies. The product is made from potato protein micro particles and is naturally hypoallergenic and cost effective to produce.
Based on protein composition, the protein for diabetes care patients segment is likely to hold significant market share in 2019. This is owing to high demand for protein supplements and rising incidence of diabetes in Brazil. For instance, According to International Diabetes Federation, around 12,465,800 people in Brazil had diabetes in 2017 and the prevalence rate of diabetes in Brazil is around 8.7%.

Key players operating in the Brazil enteral nutrition market include—

Abbott Laboratories, Prodiet Nutrição Clínica, Nestlé S.A., Danone, Royal Friesland Campina, Baxter International Inc., Nutrimed, B. Braun Melsungen AG, Pfizer, Inc., Reckitt Benckiser Group plc, Eurofarma, Nuteral, Fresenius Kabi AG, and Nutricium.

Buy this Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/3540

Market Segmentations:

Global Lysosomal Storage Diseases Therapeutics Market, By Treatment:

Enzyme Replacement Therapy

Stem Cell Therapy
Substrate Reduction Therapy
Others

Global Lysosomal Storage Diseases Therapeutics Market, By Indication:

Gaucher's Disease
Fabry Disease
Pompe's Syndrome
Mucopolysaccharidosis
Others

Global Lysosomal Storage Diseases Therapeutics Market, By End User:

Hospitals
Clinics

Global Lysosomal Storage Diseases Therapeutics Market, By Geography:

North America

U.S.
Canada

Europe

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

Middle East:

GCC
Israel
Rest of Middle East

Africa

Central Africa
South Africa
North Africa

Did not find what you were looking for? Here are some similar topics:

DIABETIC GASTROPARESIS TREATMENT MARKET

Diabetic gastroparesis involves digestive system issue associated with diabetes. Chronic Diabetes hampers functioning of various organs, and nervous system including vagus nerve. Vagus nerve controls stomach emptying activity or the time duration for stomach emptying i.e. how quick or slow. Damaged vagus serve affects digestion, and food stays for longer time in the body than required.

INDIA INTRAVENOUS ANESTHETIC MARKET

The group of fast-acting compounds that are used to induce complete sedation are known as intravenous anesthetics. Propofol, etomidate, ketamine, and barbiturates are the most commonly used intravenous anesthetics. Ketamine is used in the emergency medicine cases, owing to its strong dissociative, sympathomimetic, and analgesic effects. Propofol is the standard drug for induction of anesthesia and etomidate is most commonly used in the cases of hemodynamic instability.

SAUDI ARABIA PHARMACEUTICALS MARKET

Pharmaceuticals market constitutes of medicinal products sold as patented/prescription and OTC products. There are two types of pharmaceutical products namely; prescription products and OTC. Increasing healthcare expenditure is also expected to aid in growth of the market. Moreover, increasing prevalence of lifestyle diseases along with increasing investment in halal pharmaceuticals in Saudi Arabia is also expected to aid in growth of the market.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

SOURCE Coherent Market Insights